# Citius Pharmaceuticals, Inc.: Form 8-K, filed Feb 14, 2025

- Company: [Citius Pharmaceuticals, Inc.](/companies/ctxr.md) (CIK 1506251)
- Form: 8-K
- Filed: 2025-02-14
- Accepted by EDGAR: Feb 14, 2025, 16:47 ET
- Period: 2025-02-14
- Accession: 0001213900-25-014359
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1506251/000121390025014359/ea0231245-8k_citius.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1506251/000121390025014359/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1506251/000121390025014359/ea0231245-8k_citius.htm

Filed Feb 14, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-014359. Last ingested by Listed: Oct 26, 2026, 16:06 ET. No prices; not investment advice.